|
1. Biologie
|
|
|
|
3.1 Prévention - Tabac
|
|
|
|
3.8 Prévention - Alimentation
|
|
|
Three cups of coffee a day 'may have health benefits' [BBC News]
|
|
|
|
|
|
Moderate
coffee drinking is safe, and three to four cups a day may have some
health benefits, according to a large review of studies, in the BMJ. It
found a lower risk of liver disease and some cancers in coffee drinkers,
and a lower risk of dying from stroke - but researchers could not prove
coffee was the cause.
|
|
|
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
New EudraVigilance system is live [EMA]
|
|
|
|
|
|
The
new system makes it easier for marketing authorisation holders and
sponsors of clinical trials to report suspected adverse reactions and
allows for better analysis of this information for the benefit of
patient safety in Europe.
|
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
Roche’s Erivedge no longer funded by the NHS [PharmaTimes]
|
|
|
|
|
|
Erivedge
(vismodegib) was made available to patients with advanced basal cell
carcinoma (BCC) unable to receive surgery or radiotherapy via the old
CDF in 2013. But following a reappraisal, NICE’s committee concluded
that its clinical benefit was unclear.
|
|
|
|
|
|
|
|
6.1 Observation
|
|
|
|
|
6.6 Publications
|
|
|
US court issues injunction against OMICS to stop “deceptive practices” [Retraction Watch]
|
|
|
|
|
|
The
FTC alleged the defendants used the names of prominent researchers to
draw conference attendees, even though the researchers had not agreed to
participate; misled readers about whether articles had been peer
reviewed; failed to provide authors with transparent information about
publishing fees prior to submission; and presented misleading “impact
factors” for journals.
|
|
|
|
|
|
|